{"id":"W4409980303","doi":"10.1002/cpt.3616","title":"Modeling and Simulation to Inform Apixaban Dosing in Pediatrics With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma Treated With Asparaginase","year":2025,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta","funders":"Pfizer; Bristol-Myers Squibb","keywords":"Lymphoblastic lymphoma; Lymphoblastic Leukemia; Dosing; Asparaginase; Medicine; Lymphoma; Acute lymphocytic leukemia; Oncology; Pediatrics; Internal medicine; Leukemia; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005772645,0.0005792864,0.0006177,0.0003332947,0.0002715566,0.0008276504,0.0006936014,0.0007706783,0.001713887],"category_scores_gemma":[0.00252956,0.0004265294,0.0007781917,0.0003717381,0.0002041704,0.0005050636,0.0004565378,0.0008301752,0.0002416264],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009916939,"about_ca_system_score_gemma":0.001823465,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.03117092,"about_ca_topic_score_gemma":0.01555303,"domain_scores_codex":[0.9997128,0.0001526317,0.00001620809,0.00003858553,0.00004678088,0.00003298605],"domain_scores_gemma":[0.9989213,0.0007783156,0.00011078,0.00003408376,0.0001148925,0.00004066427],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.00004164971,0.00002270051,0.002560666,0.00001424075,0.00002288497,0.00005032411,0.00001737938,0.9940003,0.0002188416,0.0008267432,0.0002353021,0.00198907],"study_design_scores_gemma":[0.00001370551,0.00001995541,0.0003069566,0.00000374786,0.00001103279,0.00001278733,0.000009099482,0.9984849,0.0001321603,0.0005117395,0.0004907463,0.000003231288],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.6230692,0.001435528,0.3489947,0.00255647,0.0001382271,0.0002843238,0.003200863,0.001287106,0.0190336],"genre_scores_gemma":[0.9635879,0.0008104141,0.03181912,0.0001580465,0.00003366073,0.0001958156,0.001064536,0.00007872955,0.00225174],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03117092,"threshold_uncertainty_score":0.06197894,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08085524973616941,"score_gpt":0.4362556578160278,"score_spread":0.3554004080798583,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}